Foamix Pharmaceuticals (FOMX) PT Lowered to $15 at Cowen, Positive on Deal
Tweet Send to a Friend
Cowen analyst Ken Cacciatore lowered the price target on Foamix Pharmaceuticals (NASDAQ: FOMX) to $15.00 (from $30.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
